KPV

What it is

KPV is the lysine–proline–valine tripeptide, corresponding to the C-terminal end of α-MSH. 10 mg lyophilized vial.

What research explores

• C-terminal α-MSH fragments
• Inflammation and barrier assays in cell models
• Interaction with melanocortin pathways without the full domain
• Tripeptide stability in laboratory media

Studies

Predominantly preclinical. Controlled human data for this isolated fragment are limited or absent.

Reported effects

In-vitro / animal models describe changes in local inflammatory markers. No dermatological or GI consumer claims.

In the literature

Published ranges are model-dependent. CodePept does not publish a protocol.

Specs

Format

Lyophilized powder

Quantity

10 mg

Store per the lot sheet, typically refrigerated and protected from light.

Lot: as stated by the manufacturer on the vial

Manufacturer COA — shown when the file exists in the data

Research use

Research use only (RUO). Not for human consumption.